Navigation Links
Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
Date:11/19/2010

SAN DIEGO, Nov. 19, 2010 /PRNewswire-FirstCall/ -- Marshall Edwards, Inc.(Nasdaq: MSHL), an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced today that it was notified on November 16, 2010 by the Listing Qualifications Staff of The NASDAQ Stock Market that, due to the Company's non-compliance with the minimum $10 million stockholders' equity requirement for continued listing on The NASDAQ Global Market, as set forth in Listing Rule 5450(b)(1), the Company's common stock is subject to delisting unless the Company requests a hearing before a NASDAQ Listing Qualifications Panel. The Company intends to timely request a hearing before the Panel, which request will stay any further action by NASDAQ until the Panel issues its decision following the hearing. In connection with the hearing, the Panel may grant the Company an additional compliance period of up to 180 calendar days from the date of the NASDAQ staff's determination, or May 16, 2011, to evidence compliance with the minimum stockholders' equity requirement for continued listing on The NASDAQ Global Market. While the Company is working diligently to remedy the listing deficiency, there can be no assurance that the Panel will grant the Company's request for continued listing on The NASDAQ Global Market and, if the Panel does not, the Company's common stock may be transferred to The NASDAQ Capital Market or delisted from NASDAQ.

About Marshall Edwards

Marshall Edwards, Inc. (Nasdaq: MSHL) is a San Diego-based oncology company focused on the clinical development of novel anti-cancer therapeutics. The Company's pipeline is derived from an investigational isoflavone technology platform that has generated a number of compounds with anti-proliferative activity in human cancer cell lines.
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Marshall Edwards Announces Presentation of New Data Showing Activity in Chemotherapy-Resistant Ovarian Cancer Cells
2. Edwards Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
3. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
8. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
9. CryoCor Receives FDA Approval for Right Atrial Flutter
10. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
11. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... CORAL SPRINGS, Florida , August 3, ... and development agreements between biotech companies, military ... biotech solutions & therapies with regards to ... to positive clinical enhancements for regenerative medicine ... with recent developments, partnerships and advancements in ...
(Date:8/3/2015)... -- BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical ... J. Whelan , President will be interviewed by ... 9am EDT on Wednesday, August 5 th .  To ... http://tunein.com/radio/Money-Matters-Boston-1120-s27548/ Mr. Whelan is ... flagship product, ActiPatch Therapy, is achieving in the UK.  ...
(Date:8/3/2015)...  Charleston Laboratories, Inc., an emerging specialty pharmaceutical ... program with a Phase 1 study on its ... contains fast-dissolving promethazine and sumatriptan.  This novel migraine ... migraine headache pain and migraine-induced nausea and vomiting ... headaches also suffer from nausea and vomiting," said ...
Breaking Medicine Technology:Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 2Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 3Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 5Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 6UpTick News Wire Radio Show Will Interview BioElectronics' CEO Andrew Whelan 2Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2
... N.Y., May 8, 2012  Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Arthritis Advisory Committee of the U.S. Food and ... (rilonacept) Injection for Subcutaneous Use for the proposed ... patients initiating uric acid-lowering therapy.  The Committee,s recommendation ...
... May 8, 2012 Stereotaxis, Inc. (NASDAQ:   ... to the European market the V-Sono™ intracardiac echocardiography ... Designed to manipulate accessory devices such ... catheters, the Vdrive™ platform combines magnetic navigation with ...
Cached Medicine Technology:Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection 2Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection 3Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection 4Stereotaxis Releases V-Sono™ Intracardiac Echocardiography Module for the Vdrive™ Remote Navigation System 2Stereotaxis Releases V-Sono™ Intracardiac Echocardiography Module for the Vdrive™ Remote Navigation System 3
(Date:8/3/2015)... Pass, OR (PRWEB) , ... August 03, 2015 ... ... Northeast California’s Modoc National Forest, to Ahjumawi Lava Springs, California’s northernmost and among ... of California’s largest untapped ground water aquifers, whose main outflow is at Ahjumawi ...
(Date:8/3/2015)... ... August 03, 2015 , ... From ... by 39 percent, according to market research compiled for the National Association of ... U.S. Department of Labor, Bureau of Labor Statistics. As the number of dental ...
(Date:8/3/2015)... ... , ... Constantin Vasilica, 48 from Romania wanted to have an alternative healing ... years of suffering and using medications with strong side effects. This had already forced ... time off or wait longer hours in the waiting rooms. Instead, he went home ...
(Date:8/3/2015)... ... August 03, 2015 , ... The ... (ICC) announce an agreement to collaborate across a wide range of initiatives ranging ... code knowledge among architects. , “Our combined membership, consisting of practicing design professionals, ...
(Date:8/2/2015)... ... , ... A new Phase I research study is looking at a vaccine ... Kenneth G. Lucas, M.D. , chief of the division of pediatric hematology/oncology and ... Kosair Children’s Hospital and in the UofL Department of Pediatrics . Patients ...
Breaking Medicine News(10 mins):Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 2Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 3Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 2Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 3Health News:UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hospital 2
... News) -- Not a big fan of bacon or ham? ... Researchers found that 70 percent of participants had two functional copies ... brain. This cellular receptor is attuned to a compound in male ... the study, 23 people were asked to smell pork. Those with ...
... Mann HealthDay Reporter , WEDNESDAY, May 2 (HealthDay News) ... avian (bird) flu virus can morph -- with the possibility that ... pandemic -- may help nations prepare for the impending threat. ... the study in the May 2 online issue of Nature ...
... California, Davis, are among 12 scientists selected to receive ... year. The awards provide $100,000 of direct support each ... equipment for periodic communications with the foundation and other ... Davis Hartwell Foundation postdoctoral researcher with $50,000 per year ...
... research has focused on the delivery of established and ... different approach. They developed nanoparticle carriers to successfully deliver ... failed clinical development due to pharmacologic challenges. They report ... 2012 early online edition of Proceedings of the ...
... 2012The first-ever national, regional, and global estimates of preterm birth ... year and 1.1 million of those babies die shortly after ... children under age 5. The alarming statistics in ... Global Action Report on Preterm Birth, highlight the need for ...
... News) -- Chemistry in three areas of the brain ... says. Along with providing new information about how ... finding ways to treat depression, schizophrenia, attention-deficit disorder and ... Vanderbilt University researchers said. The researchers monitored brain ...
Cached Medicine News:Health News:Once-Banned Bird Flu Study Suggests Pandemic Threat Is Real 2Health News:Once-Banned Bird Flu Study Suggests Pandemic Threat Is Real 3Health News:Biomedical researchers receive Hartwell Foundation awards 2Health News:Biomedical researchers receive Hartwell Foundation awards 3Health News:UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery 2Health News:New report shows 15 million babies born too soon every year 2Health News:Clues to 'Slacker' Behavior Found in Brain, Study Says 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: